PAHC Stock Overview
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
My Notes
NewNotes are coming soon
Phibro Animal Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$15.25 |
| 52 Week High | US$22.16 |
| 52 Week Low | US$11.75 |
| Beta | 0.53 |
| 1 Month Change | 13.72% |
| 3 Month Change | 2.49% |
| 1 Year Change | -20.98% |
| 3 Year Change | -35.76% |
| 5 Year Change | -52.64% |
| Change since IPO | -10.29% |
Recent News & Updates
Recent updates
Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?
Dec 23
Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Aug 26Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?
Aug 24Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Jul 29Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
May 06Phibro Animal Health (NASDAQ:PAHC) Has Announced A Dividend Of US$0.12
Feb 11Phibro Animal Health (NASDAQ:PAHC) Has Re-Affirmed Its Dividend Of US$0.12
Nov 05We Discuss Why Phibro Animal Health Corporation's (NASDAQ:PAHC) CEO Compensation May Be Closely Reviewed
Oct 26Does Phibro Animal Health (NASDAQ:PAHC) Have A Healthy Balance Sheet?
Aug 26Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
Jul 30Is There An Opportunity With Phibro Animal Health Corporation's (NASDAQ:PAHC) 43% Undervaluation?
Jun 23Is Phibro Animal Health Corporation (NASDAQ:PAHC) A Smart Pick For Income Investors?
Mar 18Phibro Animal Health Corporation (NASDAQ:PAHC) Goes Ex-Dividend Soon
Feb 25We Think Phibro Animal Health (NASDAQ:PAHC) Is Taking Some Risk With Its Debt
Feb 16A Look At Phibro Animal Health's (NASDAQ:PAHC) CEO Remuneration
Jan 29
Would Shareholders Who Purchased Phibro Animal Health's (NASDAQ:PAHC) Stock Three Years Be Happy With The Share price Today?
Jan 14Calculating The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)
Dec 30Should You Or Shouldn't You: A Dividend Analysis on Phibro Animal Health Corporation (NASDAQ:PAHC)
Dec 15Is Phibro Animal Health Corporation (NASDAQ:PAHC) A High Quality Stock To Own?
Nov 30Shareholder Returns
| PAHC | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | -1.2% | -1.4% | 2.8% |
| 1Y | -21.0% | 4.5% | -9.2% |
Return vs Industry: PAHC underperformed the US Pharmaceuticals industry which returned 4.5% over the past year.
Return vs Market: PAHC underperformed the US Market which returned -9.2% over the past year.
Price Volatility
| PAHC volatility | |
|---|---|
| PAHC Average Weekly Movement | 4.6% |
| Pharmaceuticals Industry Average Movement | 11.1% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: PAHC is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: PAHC's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1946 | 1,860 | Jack Bendheim | https://www.pahc.com |
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Phibro Animal Health Corporation Fundamentals Summary
| PAHC fundamental statistics | |
|---|---|
| Market Cap | US$617.68m |
| Earnings (TTM) | US$46.50m |
| Revenue (TTM) | US$960.12m |
13.3x
P/E Ratio0.6x
P/S RatioIs PAHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PAHC income statement (TTM) | |
|---|---|
| Revenue | US$960.12m |
| Cost of Revenue | US$670.43m |
| Gross Profit | US$289.68m |
| Other Expenses | US$243.19m |
| Earnings | US$46.50m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Feb 08, 2023
| Earnings per share (EPS) | 1.15 |
| Gross Margin | 30.17% |
| Net Profit Margin | 4.84% |
| Debt/Equity Ratio | 177.8% |
How did PAHC perform over the long term?
See historical performance and comparison